home / stock / achv / achv news


ACHV News and Press, Achieve Life Sciences Inc. From 03/10/22

Stock Information

Company Name: Achieve Life Sciences Inc.
Stock Symbol: ACHV
Market: NASDAQ
Website: achievelifesciences.com

Menu

ACHV ACHV Quote ACHV Short ACHV News ACHV Articles ACHV Message Board
Get ACHV Alerts

News, Short Squeeze, Breakout and More Instantly...

ACHV - Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q4 2021 Results - Earnings Call Transcript

Achieve Life Sciences, Inc. (ACHV) Q4 2021 Earnings Conference Call March 10, 2022 04:30 PM ET Company Participants John Bencich - Chief Executive Officer Jerry Wan - Principal Accounting Officer Cindy Jacobs - President & Chief Medical Officer Conference Call Participants Thomas Flaten -...

ACHV - Achieve Life Sciences GAAP EPS of -$0.76 misses by $0.07

Achieve Life Sciences press release (NASDAQ:ACHV): Q4 GAAP EPS of -$0.76 misses by $0.07. As of December 31, 2021, the company’s cash, cash equivalents, and restricted cash was $43.1 million. For further details see: Achieve Life Sciences GAAP EPS of -$0.76 misses by $0.07

ACHV - Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update

SEATTLE and VANCOUVER, British Columbia, March 10, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today anno...

ACHV - Achieve Life Sciences Q4 2021 Earnings Preview

Achieve Life Sciences (NASDAQ:ACHV) is scheduled to announce Q4 earnings results on Thursday, March 10th, after market close. The consensus EPS Estimate is -$0.70 (+36.9% Y/Y) and the consensus Revenue Estimate is $0.03M Over the last 3 months, EPS estimates have seen 0 upward revisions and 1...

ACHV - Achieve Life Sciences Announces Participation in March Investor Conferences

SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, tod...

ACHV - Achieve Life Sciences to Announce Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call and Webcast on March 10, 2022

SEATTLE and VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today annou...

ACHV - Catalyst Watch for next week: Eyes on Uber, Hertz, Amgen, Peloton and AMD

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

ACHV - Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Award

SEATTLE and VANCOUVER, British Columbia, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today annou...

ACHV - Achieve Life Sciences Announces Participation in February Investor Conferences

SEATTLE and VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today annou...

ACHV - 36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8 th - 11 th , 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The vir...

Previous 10 Next 10